Could a common blood thinner help fight ovarian cancer?
NCT ID NCT05284552
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether adding the blood thinner tinzaparin to standard chemotherapy can improve outcomes for women with advanced ovarian cancer. About 40 participants will receive either chemotherapy plus tinzaparin or chemotherapy alone. The main goal is to see if tinzaparin affects a key tumor marker called CA-125.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tinzaparin (Innohep), a blood thinner
- What this could lead to
- If it works, this could point toward a way to make chemotherapy more effective for advanced ovarian cancer.
- What could go wrong
- This is a very small, early pilot study. It may not show a clear benefit, and the blood thinner carries a risk of bleeding.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Obstetrics and Gynaecology, Norrland University Hospital
RECRUITINGUmeå, Umeå, 90719, Sweden
-
Department of Obstetrics and Gynecology, Highland Hospital
RECRUITINGEksjö, Eksjö, 575 81, Sweden
-
Department of Obstetrics and Gynecology, Ryhov County Hospital
RECRUITINGJönköping, Jönköping County, 55305, Sweden
-
Department of Obstetrics and Gynecology, University Hospital
ACTIVE_NOT_RECRUITINGLinköping, Östergötland County, 58185, Sweden
-
Department of Obstetrics and Gynecology, Värnamo Hospital
RECRUITINGVärnamo, Värnamo, 33152, Sweden
-
Department of Obstetrics and Gynecology, Västervik Hospital
RECRUITINGVästervik, Västervik, 593 81, Sweden
-
Department of Oncology, Linköping University Hospital
RECRUITINGLinköping, Linköping, 58185, Sweden
-
Department of Oncology, Sahlgrenska University Hospital
RECRUITINGGothenburg, Gothenburg, 41345, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Metabolic clues: could your Body's energy use predict ovarian cancer outcomes?
- Can a custom vaccine train the body to fight ovarian cancer?
- Can a 'Smart Bomb' drug outsmart recurrent ovarian cancer?
- Can a targeted drug boost standard ovarian cancer therapy?
- Can heated chemo during surgery help older women with ovarian cancer?
- Can a daily pill keep BRCA-Linked ovarian cancer at bay?